Quality of life in women with early-stage and metastatic hormone receptor-positive, HER2-negative breast cancer receiving endocrine therapy.
O'Reilly D, Farooq AR, Nevins Selvadurai P, Sheehan L, Molan K, Krishnanivas B, Mullen V, McMahon D, Hadi D, Ahmed A, Jennings M, Carroll H, Chew S, Macanovic B, O'Hanlon Brown C, Noonan SA, O Reilly S, Connolly RM, Cahir C, Kelly CM.
O'Reilly D, et al. Among authors: sheehan l.
Oncologist. 2024 Oct 3;29(10):842-849. doi: 10.1093/oncolo/oyae146.
Oncologist. 2024.
PMID: 38906704
Free PMC article.